Quality Assurance in Diabetes Drug Development – Sitagliptin Phosphate Hydrate Impurity B by Pharmaffiliates
Quality Assurance in Diabetes Drug Development
Pharmaceutical research and development relies heavily on precise reference materials to ensure drug safety, efficacy, and compliance with regulatory guidelines. Among these, Sitagliptin Phosphate Hydrate – Impurity B holds significant value, particularly in the study and quality control of type 2 diabetes therapies.
Understanding the Compound
Sitagliptin is a well-established dipeptidyl peptidase-4 (DPP-4) inhibitor, widely prescribed for the management of type 2 diabetes. Impurities associated with this compound, such as Impurity B (chemically known as 4-Desfluoro Sitagliptin), must be thoroughly monitored and characterized to maintain strict pharmaceutical quality standards.
Chemical Identity
-
Chemical Name: 4-Desfluoro Sitagliptin
-
CAS Number: 1345822-87-8
-
Molecular Formula: C₁₆H₁₉F₅N₅O₅P
-
Molecular Weight: 487.32 g/mol
-
Classification: Aromatic compound, chiral standard, heterocycle, enzyme inhibitor, pharmaceutical intermediate
These properties make Sitagliptin Phosphate Hydrate – Impurity B an essential tool in analytical method development, validation, and impurity profiling studies.
Role in Quality Control
Reference standards like this impurity are crucial for:
-
Ensuring Safety: Detecting and quantifying impurities that may impact patient safety.
-
Regulatory Compliance: Supporting dossier submissions, method validation, and global quality audits.
-
R&D Efficiency: Facilitating robust analytical methods for consistent drug manufacturing.
Storage and Stability
To preserve its integrity, Sitagliptin Phosphate Hydrate – Impurity B is recommended to be stored at 2–8 °C under controlled conditions. This ensures the compound remains stable and reliable for laboratory and industrial use.
Sitagliptin Phosphate Hydrate – Impurity B is more than just a chemical reference—it is a vital element in the chain of pharmaceutical research and quality assurance. By providing accurate characterization and consistent quality, it empowers researchers, manufacturers, and regulatory professionals to uphold the highest standards in diabetes drug development.
Comments
Post a Comment